Rangeley Capital’s Vigil Neuroscience VIGL Stock Holding History

Rangeley Capital’s Portfolio VIGL Stock Details VIGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-67,800	Closed	-$539K	–	146
2025 Q2	$539K	Buy	+67,800	New	+$304K	0.64%	34

Other funds holding VIGL

Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return

Rangeley Capital's VIGL Position: Q3 2025 in Review

Rangeley Capital sold out of Vigil Neuroscience (VIGL) in Q3 2025, closing a stake of 67,800 shares — an estimated $539K sold.

Rangeley Capital first reported a position in VIGL in Q2 2025 and held it in 1 quarter. The position peaked at $539K in Q2 2025. 2 funds tracked by Wall St. Rank hold VIGL as of Q3 2025.

Rangeley Capital reported no remaining Vigil Neuroscience position as of Q3 2025 after selling out during the quarter.
Rangeley Capital sold 67,800 Vigil Neuroscience shares in Q3 2025, an estimated $539K.
Rangeley Capital first reported a position in Vigil Neuroscience in Q2 2025 and held it in 1 quarter.
Rangeley Capital's Vigil Neuroscience position peaked at $539K in Q2 2025.
2 funds tracked by Wall St. Rank held Vigil Neuroscience as of Q3 2025.

Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.